Doctors say seasonal allergies are hitting hard this year — and in the Southeast, drought conditions may be making symptoms even worse.

HANGZHOU, China, May 7, 2026 /PRNewswire/ -- ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated ...

Most people in Uganda living with asthma remain undiagnosed and unable to access lifesaving inhalers, said a report as the East African country marked the World Asthma Day 2026 on Thursday.The report ...

Brits who puff on blue inhalers to open their airways and ease their breathing have been urged to reconsider their 'asthma ...

Schulich professor Dr. Samira Jeimy is an expert in clinical allergy and immunology explains how to ease spring and seasonal allergies.

Symptoms include wheezing, shortness of breath, recurrent cough, and chest tightness. Fear of cortisone remains one of the ...

Chaotic scenes of migrants clambering over the walls of an embassy in Spain have renewed controversy over a mass amnesty ...

Evidence given by Morgan McSweeney to a committee of MPs investigating Mandelson’s appointment as Washington Ambassador are ...

FDA clearance positions budesonide/glycopyrrolate/formoterol as the sole US single-inhaler triple therapy for asthma in patients aged ≥12 years. Replicate KALOS ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...

Since discontinuing its two branded versions of asthma inhaler Flovent at the start of 2024, GSK has still produced “authorized generic” versions of the treatment, which are the same products with ...

– Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 and 400 mg q24 week dosing – – Verekitug also ...